COMPASS THERAPEUTICS, INC. Operating Cash Flow
COMPASS THERAPEUTICS, INC. (CMPX) reported Operating Cash Flow of -$32.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$14.74M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$17.27M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$13.25M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$10.85M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$49.14M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$44.85M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$40.62M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$34.13M.
| Period end | Net Cash Provided by (Used in) Operating Activities 0 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$14.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$32.01M 10-Q · filed 2026-08-06 | -$45.26M derived: sum of 3 quarters · filed 2026-08-06 | -$56.11M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$17.27M 10-Q · filed 2026-05-05 | -$30.52M derived: sum of 2 quarters · filed 2026-05-05 | -$41.37M derived: sum of 3 quarters · filed 2026-05-05 | -$53.20M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$13.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$24.10M derived: sum of 2 quarters · filed 2026-03-05 | -$35.94M derived: sum of 3 quarters · filed 2026-08-06 | -$49.14M 10-K · filed 2026-03-05 | |
| 2025-09-30 | -$10.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$22.68M derived: sum of 2 quarters · filed 2026-08-06 | -$35.89M 10-Q · filed 2025-11-05 | -$45.05M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$11.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$25.04M 10-Q · filed 2026-08-06 | -$34.20M derived: sum of 3 quarters · filed 2026-08-06 | -$45.25M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$13.21M 10-Q · filed 2026-05-05 | -$22.37M derived: sum of 2 quarters · filed 2026-05-05 | -$33.42M derived: sum of 3 quarters · filed 2026-05-05 | -$44.17M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$9.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$20.21M derived: sum of 2 quarters · filed 2026-03-05 | -$30.97M derived: sum of 3 quarters · filed 2026-03-05 | -$44.85M 10-K · filed 2026-03-05 | |
| 2024-09-30 | -$11.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$21.80M derived: sum of 2 quarters · filed 2025-11-05 | -$35.69M 10-Q · filed 2025-11-05 | -$48.05M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | -$10.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$24.64M 10-Q · filed 2025-08-11 | -$37.00M derived: sum of 3 quarters · filed 2025-08-11 | -$42.92M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | -$13.89M 10-Q · filed 2025-05-08 | -$26.24M derived: sum of 2 quarters · filed 2025-05-08 | -$32.16M derived: sum of 3 quarters · filed 2025-05-08 | -$42.28M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$18.28M derived: sum of 2 quarters · filed 2025-02-27 | -$28.39M derived: sum of 3 quarters · filed 2025-02-27 | -$40.62M 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$16.04M derived: sum of 2 quarters · filed 2024-11-12 | -$28.26M 10-Q · filed 2024-11-12 | -$38.91M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$10.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$22.34M 10-Q · filed 2024-08-12 | -$32.98M derived: sum of 3 quarters · filed 2024-08-12 | -$43.92M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | -$12.23M 10-Q · filed 2024-05-13 | -$22.87M derived: sum of 2 quarters · filed 2024-05-13 | -$33.81M derived: sum of 3 quarters · filed 2024-05-13 | -$38.41M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$10.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$21.58M derived: sum of 2 quarters · filed 2024-03-21 | -$26.18M derived: sum of 3 quarters · filed 2024-03-21 | -$34.13M 10-K · filed 2024-03-21 | |
| 2022-09-30 | -$10.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$15.54M derived: sum of 2 quarters · filed 2023-11-09 | -$23.48M 10-Q · filed 2023-11-09 | -$28.15M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$12.54M 10-Q · filed 2023-08-03 | -$17.21M derived: sum of 3 quarters · filed 2023-08-03 | -$20.66M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$7.94M 10-Q · filed 2023-05-04 | -$12.61M derived: sum of 2 quarters · filed 2023-05-04 | -$16.06M derived: sum of 3 quarters · filed 2023-05-04 | -$22.00M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | -$4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$8.12M derived: sum of 2 quarters · filed 2023-03-15 | -$14.06M derived: sum of 3 quarters · filed 2023-03-15 | -$19.67M 10-K · filed 2023-03-15 | |
| 2021-09-30 | -$3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$9.40M derived: sum of 2 quarters · filed 2022-11-09 | -$15.00M 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$5.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$11.54M 10-Q · filed 2021-08-16 | |||
| 2021-06-20 | -$5.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | -$11.54M 10-Q · filed 2022-08-01 | -$18.12M derived: sum of 3 quarters · filed 2022-08-01 | -$25.29M derived: sum of 4 quarters · filed 2022-08-01 | |
| 2021-03-31 | -$5.61M 10-Q · filed 2022-05-09 | -$12.18M derived: sum of 2 quarters · filed 2022-05-09 | -$19.35M derived: sum of 3 quarters · filed 2022-05-09 | -$24.65M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | -$6.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$13.74M derived: sum of 2 quarters · filed 2022-03-18 | -$19.04M derived: sum of 3 quarters · filed 2022-03-18 | -$26.80M 10-K · filed 2022-03-18 | |
| 2020-09-30 | -$7.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$12.47M derived: sum of 2 quarters · filed 2021-11-12 | -$20.23M 10-Q · filed 2021-11-12 | -$20.24M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$13.06M 10-Q · filed 2021-08-16 | -$13.07M derived: sum of 3 quarters · filed 2021-08-16 | -$19.77M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$7.76M 10-Q · filed 2021-04-30 | -$7.77M derived: sum of 2 quarters · filed 2021-04-30 | -$14.47M derived: sum of 3 quarters · filed 2021-04-30 | -$32.11K 10-K · filed 2020-06-08 | |
| 2019-12-31 | -$7.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | -$6.71M derived: sum of 2 quarters · filed 2020-11-09 | -$24.71K 10-Q · filed 2020-02-14 | -$31.74M 10-K · filed 2021-03-05 | |
| 2019-09-30 | -$6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$17.47K 10-Q · filed 2019-11-13 | -$26.15M 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$19.45M 10-Q · filed 2020-08-13 | ||||
| 2019-03-31 | -$9.81K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-08 | -$20.08K derived: sum of 2 quarters · filed 2020-06-08 | -$24.86K derived: sum of 3 quarters · filed 2020-06-08 | -$32.76K 10-K · filed 2020-06-08 | |
| 2018-12-31 | -$10.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | -$15.05K derived: sum of 2 quarters · filed 2020-02-14 | -$22.95K 10-Q · filed 2020-02-14 | ||
| 2018-09-30 | -$4.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-13 | -$12.68K 10-Q · filed 2019-11-13 | |||
| 2018-06-30 | -$7.89K 10-Q · filed 2019-08-13 | ||||
| 2018-03-31 | -$35.00K 10-K · filed 2019-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |